MRK
Merck & Company Inc
148.10$
-1.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -96.8% | +1,156.1% | +82.4% | +64.8% | -62.9% | -27.5% | +31.7% | +137.5% | -63.5% | +37.1% | +37.1% | – | |
| – | -4.9% | +2.1% | +15.0% | +4.8% | +0.9% | -8.2% | +1.8% | +3.1% | +22.9% | +6.6% | +4.7% | – | |
| – | +1.8% | +5.4% | +15.3% | -3.9% | -4.1% | +4.3% | +10.8% | -5.6% | +0.5% | -9.8% | +61.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -93.4% | -2,448.6% | – | – | -171.8% | – | – | – | -295.3% | – | – | – | |
| – | +9.6% | -12.9% | -8.1% | -1.0% | +19.7% | +41.7% | -42.5% | +29.2% | +4.7% | -4.1% | -9.9% | – | |
| – | – | -2,696.2% | -22.3% | +259.7% | -62.4% | +3.0% | -48.2% | -63.2% | +3,858.0% | -8.8% | -45.1% | – | |
| – | -0.2% | +5.3% | +1.8% | -1.7% | -0.1% | +5.1% | +1.3% | -2.2% | -0.6% | +4.3% | +1.9% | – | |
| – | -15.7% | -69.0% | +105.7% | +76.9% | +10.1% | +138.0% | +15.5% | – | -150.3% | -30.2% | -13.4% | – | |
| – | – | – | – | – | +53,800.0% | +363.8% | – | +12,350.0% | +31.4% | -101.0% | – | – | |
| – | -47.4% | +25.3% | – | -299.4% | +24.1% | +91.3% | -38.2% | – | +80.1% | -162.7% | – | – | |
| – | -159.5% | – | – | -41.9% | -141.3% | – | – | – | -134.5% | – | – | – | |
| – | -110.9% | – | +117.4% | +75.6% | -70.5% | -53.4% | +115.8% | +170.3% | -73.3% | +60.5% | +53.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.